| abstract |
FIELD: medicine. n SUBSTANCE: invention relates to medicine and viral infection treatment, particularly combined antiviral agent with anti-HIV action, namely the combined antiviral agent, comprising the composition of (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolane-5-yl)-1H-pyrimidine-2-on (lamivudine) and 5'-H-phosphonate-3'-azido-3'-desoxythymidine sodium salt (phosphazide) in 250:1 to 1:250 weight ratio, and the treatment for HIV-infection method. n EFFECT: producing of combined antiviral agent with anti-HIV action, providing the increase in treatment effectiveness along with significant reduction of toxic manifestations. n 12 cl, 2 tbl, 7 ex |